Rain Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.43
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.51
|
0.00
|
0.51
|
100.00%
|
|
2022-12-31
|
-0.55
|
0.00
|
0.55
|
100.00%
|
|
2022-09-30
|
-0.68
|
-0.68
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.66
|
-0.66
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.70
|
-0.66
|
0.04
|
5.71%
|
|
2021-12-31
|
-0.56
|
-0.68
|
-0.12
|
-21.43%
|
|
2021-09-30
|
-0.48
|
-0.70
|
-0.22
|
-45.83%
|
|
2021-06-30
|
-0.60
|
-0.39
|
0.21
|
35.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.00
|
|
2021-12-31
|
-3.70
|